| Description | Amivantamab (JNJ-61186372) is a bispecific antibody targeting EGFR-MET with immune anticancer properties. It prevents ligand binding, enhances receptor-antibody complex endocytosis and degradation, and triggers Fc-mediated macrophage cytokinesis and natural killer cell antibody-dependent cytotoxicity [1]. |
| molecular weight | N/A |
| CAS | 2171511-58-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |